『Pharma Sessions』のカバーアート

Pharma Sessions

Pharma Sessions

著者: Jonathan Kaskey
無料で聴く

【Amazonプライム会員限定】今ならプレミアムプランが4か月 月額99円。

10月19日まで。※適用条件あり

Navigating pharmaceutical launch excellence through strategy, technology and career stories. (And sharing fun moments too!)

© 2026 Pharma Sessions
生物科学 科学 経済学 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Data, AI, and the Future of Field Training with Annel Duckels from BMS
    2026/09/24

    In this episode, Jonathan sits down with Annel Duckels, who leads worldwide commercialization learning at Bristol Myers Squibb, to talk about modernizing pharma training through data and AI.

    • Annel's unconventional path into pharma L&D after a career in mining and heavy engineering — and what that industry taught her about listening to frontline workers
    • Why pharma lagged decades behind other industries in training technology, and what that reveals about corporate priorities
    • Moving past "check-the-box" training: building programs from the bottom up instead of top down
    • Designing individualized learning experiences instead of one-size-fits-all content
    • How AI creates a "safe space" for reps to practice and get anonymous, judgment-free feedback
    • Why clean CRM and call-note data is the invisible foundation of every AI training strategy
    • How AI is changing HCP engagement as physicians increasingly self-serve medical literature
    • Using AI to scale and personalize learning content development
    • Giving reps granular, per-conversation performance feedback — beyond what any manager could deliver manually
    • A look ahead: what pharma L&D and field enablement could look like a year from now

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    続きを読む 一部表示
    17 分
  • Hallway Interviews with Pharma Learning Leaders
    2026/07/31

    Pharma Sessions — ACTO Client Summit: Hallway Interviews

    At ACTO's 2026 client summit in Boston, we pulled some incredible minds out of the hallway for quick, candid conversations about where field excellence, AI, and learning & development are headed. No scripts, no slides — just honest takes from the people doing the work.

    In this episode, you'll hear from six pharma L&D leaders on how AI is changing their roles, what they're doing differently at national sales meetings, the adoption challenges they're navigating, and why L&D may be the most strategically important function in any AI rollout.

    Timestamps:

    • 1:43 — Andrea Penn, Senior Director of Field Training & Customer Training, Autolus Therapeutics
    • 7:38 — Sarah Barrett, Associate Director of Medical Affairs Training, Alnylam Pharmaceuticals
    • 13:10 — Brian McCann, Dupixent Market Access Training, Regeneron
    • 18:49 — Nicole Payne, Director of Global Commercial L&D, BioMarin
    • 23:08 — Erin Gigliello, Senior Product Owner & Project Manager in L&D, Accord Biopharma
    • 30:48 — Chris Richards, Head of Commercial L&D, Nuvations Bio

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    続きを読む 一部表示
    39 分
  • Blockchain + AI: The Future of Healthcare Data
    2026/07/09

    What happens when you put blockchain underneath AI in healthcare? According to Archita Samant, Head of Data Strategy & Analytics for Global Vaccines at Merck — you finally solve the interoperability problem that's been holding the industry back for decades.

    In this episode, Jonathan sits down with Archita to unpack the real-world challenges of fragmented health data, why agentic AI demands a better data foundation than we currently have, and how blockchain could be the base layer that makes personalized medicine actually possible.

    They cover:

    • Why copilots and ChatGPT aren't enough — and what agentic AI actually needs to work
    • How blockchain addresses data privacy, ownership, and interoperability across systems like Epic and Oracle Health
    • The concept of patients owning their own health data and consenting to share it for better outcomes
    • Why the EMR ecosystem is so siloed — and what it would take to fix it at an industry level
    • Real-world examples from Archita's experience with Teva's DigiHaler and predictive asthma algorithms
    • The global vaccines data problem and why even measuring disease prevalence (like dengue) is harder than you'd think
    • Why AI alone can't fix data fragmentation — and what the next five years might look like

    Archita also shares her winding path from pharmacist to founding a blockchain-based NFT charity platform to leading global data strategy at Merck — and her go-to karaoke song.

    🎙️ Pharma Sessions is a podcast where host Jonathan Kaskey has candid conversations with interesting people across the healthcare and life sciences industry.

    The views expressed are those of the individuals and do not reflect the positions of their respective employers.

    Pharma Sessions is hosted by Jonathan Kaskey

    Follow along on LinkedIn: https://www.linkedin.com/in/jonkaskey/

    Or join the Pharma Sessions Substack:
    www.pharmasessions.substack.com

    続きを読む 一部表示
    33 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません